Furthermore, the association of SDH mutations with activation of HIF1α or HIF2α, or of both transcription factors together, has been a subject of debate with conflicting published data in cell lines and tumor tissues [22,23,24]. The gene discussed is EPAS1; the disease is neoplasm.